Clinical Trial of Nobori Versus Uncoated Stents In Acute Myocardial Infarction

Trial Profile

Clinical Trial of Nobori Versus Uncoated Stents In Acute Myocardial Infarction

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 Jul 2017

At a glance

  • Drugs Umirolimus (Primary)
  • Indications Coronary artery restenosis; Myocardial infarction
  • Focus Adverse reactions
  • Most Recent Events

    • 30 Oct 2013 Planned end date changed from 1 Aug 2013 to 1 Jul 2017 as reported by ClinicalTrials.gov record.
    • 29 Jul 2011 New trial record
    • 27 Jul 2011 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top